Recruiting Atopic Dermatitis Studies in Spokane
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
This study consists of phase 1b and 2a to evaluate safety, Pharmacokinetics, and efficacy of TU2218 in combination with Pembrolizumab in patients with advanced solid tumors....
A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors
It is a Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of HB0036 in Subjects with Advanced Solid Tumors...
About Atopic Dermatitis Clinical Trials in Spokane
Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.
There are currently 2 atopic dermatitis clinical trials recruiting participants in Spokane, WA. These studies are seeking a combined 220 participants. Research is being sponsored by TiumBio Co., Ltd., Shanghai Huaota Biopharmaceutical Co., Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atopic Dermatitis Clinical Trials in Spokane — FAQ
Are there atopic dermatitis clinical trials in Spokane?
Yes, there are 2 atopic dermatitis clinical trials currently recruiting in Spokane, WA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Spokane?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Spokane research site will contact you about next steps.
Are clinical trials in Spokane free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Spokane studies also compensate for your time and travel.
What atopic dermatitis treatments are being tested?
The 2 active trials in Spokane are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.
Data updated June 2, 2026 from ClinicalTrials.gov